Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01636765 · ClinicalTrials.gov registry record
Study of Inter- and Intra-rater Reliability of the Clinician Erythema Assessment Scale
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 104
- Enrollment target
NCT01636765: Completed study, sponsored by Allergan.
NCT01636765 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 104 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01636765 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 104 participants
- Enrollment target
Study Summary
This is a study to evaluate inter- and intra-rater reliability of the Clinician Erythema Assessment Scale. There is no treatment (intervention) associated with this study.
Primary Outcome
Inter-rater agreement (among raters) of the CEA scores (0=clear skin with no signs of erythema; 1=almost clear of erythema, slight redness; 2=mild erythema, definite redness; 3=moderate erythema, marked redness; 4=severe erythema, fiery redness) evaluated using Kendall's coefficient of concordance (Kendall's W). Each of 7 raters scored 104 participant's severity of erythema due to rosacea using the CEA Scale at 2 different time points at day 1. The overall inter-rater agreement for Kendall's W f
Interventions
- DRUG No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2012-05 |
| Est. Completion | 2012-07 |
What the finished NCT01636765 record still lists
NCT01636765 is an observational study that tracks outcomes without assigning an intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT01636765 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01636765 about?
NCT01636765 is a clinical study titled "Study of Inter- and Intra-rater Reliability of the Clinician Erythema Assessment Scale". This is a study to evaluate inter- and intra-rater reliability of the Clinician Erythema Assessment Scale. There is no treatment (intervention) associated with this study.
What is the current status of trial NCT01636765?
This trial is currently completed. The enrollment target is 104 participants. The study started on 2012-05. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01636765?
The interventions under investigation include: No Intervention (DRUG).
Who is sponsoring clinical trial NCT01636765?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia